TWD 138.5
(-1.07%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -738.05 Million TWD | -63.05% |
2022 | -452.66 Million TWD | 12.63% |
2021 | -518.11 Million TWD | 7.39% |
2020 | -559.43 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | -676.64 Million TWD | 8.32% |
2024 Q2 | -676.68 Million TWD | -0.01% |
2023 Q3 | -612.12 Million TWD | 0.88% |
2023 FY | -738.05 Million TWD | -63.05% |
2023 Q1 | -584.26 Million TWD | 0.0% |
2023 Q2 | -617.57 Million TWD | -5.7% |
2023 Q4 | -738.05 Million TWD | -20.57% |
2022 Q4 | - TWD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Allied Biotech Corporation | 178.11 Million TWD | 514.375% |
GeneFerm Biotechnology Co., Ltd. | 31.92 Million TWD | 2411.768% |
Easywell Biomedicals, Inc. | 123.43 Million TWD | 697.92% |
TTY Biopharm Company Limited | -705.97 Million TWD | -4.544% |
Synmosa Biopharma Corporation | 1.52 Billion TWD | 148.515% |
Orient EuroPharma Co., Ltd. | 3.1 Billion TWD | 123.76% |
Center Laboratories, Inc. | 3.91 Billion TWD | 118.833% |
Tien Liang BioTech Co., Ltd. | -57.55 Million TWD | -1182.325% |
Orient Pharma Co., Ltd. | 633.6 Million TWD | 216.484% |
InnoPharmax Inc. | -17.85 Million TWD | -4032.91% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | -926.77 Million TWD | 20.363% |
Excelsior Biopharma Inc. | -212.51 Million TWD | -247.299% |
DV Biomed Co., Ltd. | 160.7 Million TWD | 559.275% |
Foresee Pharmaceuticals Co., Ltd. | -781.42 Million TWD | 5.55% |
Handa Pharmaceuticals, Inc. | -653.8 Million TWD | -12.886% |
UniPharma Co., Ltd. | -68.36 Million TWD | -979.549% |
Anxo Pharmaceutical Co., Ltd. | 492.4 Million TWD | 249.887% |
Winston Medical Supply Co., Ltd. | -191.81 Million TWD | -284.784% |
Mercury Biopharmaceutical Corporation | -1.94 Million TWD | -37846.272% |
Bioray Biotech Co., Ltd | -27.23 Million TWD | -2610.249% |
TSH Biopharm Corporation Limited | -568.74 Million TWD | -29.77% |